Key milestone achieved as Company advances clinical program to full approval trial of ateganosine sequenced with a checkpoint inhibitor in ...
Mucommune, a Morrisville-based biotechnology company with roots at the University of North Carolina at Chapel Hill, has been ...
Historically, non-small cell lung cancer (NSCLC) treatment involved three modalities: surgery, radiation therapy and chemotherapy. In the last two decades, the treatment landscape of NSCLC has greatly ...
Sac-TMT combined with Keytruda significantly improves progression-free survival in PD-L1-positive advanced non-small cell lung cancer. The OptiTROP-Lung05 study is the first phase 3 trial of an ...
Investing.com -- BeyondSpring Inc (NASDAQ:BYSI) shares gained 4.6% in premarket trading Friday following the company’s announcement of positive results from the Asian subset of its Phase 3 DUBLIN-3 ...
Johnson & Johnson has welcomed the decision by the Scottish Medicines Consortium (SMC) to accept Rybrevant (amivantamab) in combination with carboplatin and pemetrexed for use within NHS Scotland as a ...
BioNTech SE (NASDAQ:BNTX) is one of the best biotech stocks to buy according to Wall Street analysts. On December 8, Clear ...
Squamous cell carcinoma treatment varies by stage, involving surgery, radiation, and systemic therapies based on cancer ...
A national survey of 157 patients with non-small cell lung cancer found that all groups prioritized extending life, but ...
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced the publication of one ...
The Independent on MSN
Nine small health issues that could be an early sign of lung cancer
Nine small health issues that could be an early sign of lung cancer - As the NHS offers a ‘revolutionary’ blood test, here ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback